Option chain shows key data for RIWI's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for RIWI.

RIWI (OTC:RWCRF) Stock, Option Chain

RIWI Corp is a trend-tracking and prediction technology firm. On a monthly or annual subscription basis, the company offers its clients tracking surveys, continuous risk monitoring, predictive analytics, and ad effectiveness tests in all countries, without collecting any personally identifiable data. Geographically, it derives a majority of revenue from sales in United States. The Company generates revenue from the provision of analytical solutions to its clients in the form of compilation, analysis and communication of real-time data.

News

Penny Stocks

Health Care

Global

Markets

General

RWCRF

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

RIWI: Measuring COVID-19 Resilience Around The World

RIWI Corp

Receiving the Eichrecht certification marks a significant step towards Wallbox's expansion into DC fast charging in one of Europe's largest EV markets, and the launch of Wallbox's highest Power-to-Footprint ratio charger yet.

Wallbox Says Its Supernova DC Fast Charger Certified For Conformity According To Germany's Eichrecht Regulation

HC Wainwright &amp; Co. analyst Yi Chen maintains Regenxbio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) with a Buy and lowers the price target from $40 to $36.

Price Target

Analyst Ratings

RGNX

HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $36

The applicable waiting period under the HSR Act expired at 11:59 p.m., Eastern time, on November 20, 2024.&nbsp;
The expiration of the waiting period under the HSR Act satisfies an important condition necessary for the completion of the Proposed Transaction, which is expected to close by the end of the third quarter of 2025, and remains subject to other conditions and regulatory approvals.
 &nbsp;

EVRI

IGT Reports Expiration Of HSR Act Waiting Period, In Connection With Proposed Deal Whereby IGT Gaming And Everi Will Be Simultaneously Acquired By Newly Formed Holding Company Owned By Apollo

Barclays analyst Brian Morton upgrades Royal Bank of Canada (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RY#TSX">RY</a>) from Equal-Weight to Overweight and raises the price target from C$150 to C$180.

Upgrades

TSX:RY

Barclays Upgrades Royal Bank of Canada to Overweight, Raises Price Target to C$180

Retail Sales

Buybacks

BJ's Wholesale Club's Board Approves New $1B Share Repurchase Program

U.S. stocks could open on a negative note on Thursday after AI bellwether Nvidia Corp.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42107846/nvidia-slides-during-thursday-pre-market-despite-beating-q3-estimates-even-outstanding-isnt-enough-for-some-investors">guidance fell short</a> of some expectations. Futures of all three major indices were down as investors processed the AI giant's earnings.
Other chip makers like Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) also experienced pressure in premarket trading.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.33%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.24%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.08%</td>
</tr>
<tr>
<td>R2K</td>
<td>-0.22%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Thursday,&nbsp;the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.25% to $589 and the&nbsp;Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) declined 0.34% to $501.46, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Cues From Last Session:
The Dow Jones snapped its two-session losing streak this week to close 100 points higher on Wednesday, while the S&amp;P 500 eked a marginal gain to close in the green.
The tech-heavy Nasdaq, however, fell ahead of the volatility due to Nvidia's earnings after the bell.
Crude oil prices continued to rise amid growing tensions between Russia and Ukraine but remained under the $70 mark.
Treasury yields eased slightly as investors waited for further economic data.
On the economic data front, mortgage applications in the U.S. rose 1.7% from the previous week in the week ending Nov. 15, compared to a 0.5% gain in the prior period.
Most sectors on the S&amp;P 500 closed on a positive note, with healthcare, energy, and materials stocks recording the biggest gains on Wednesday.
However, consumer discretionary and financial stocks bucked the overall market trend, closing the session lower.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.11%</td>
<td>18,966.14</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.002%</td>
<td>5,917.11</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.32%</td>
<td>43,408.47</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.03%</td>
<td>2,325.53</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Ryan Detrick, chief market strategist at Carson Group, maintained that despite the weakness in the markets currently, he remains optimistic about the potential of a continued bull run.
"Weakness right around now is perfectly normal. The good news is I wouldn&#8217;t give up on a late November rally."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Weakness right around now is perfectly normal. The good news is I wouldn&#39;t give up on a late November rally. <a href="https://t.co/NuU2qzpDsC">pic.twitter.com/NuU2qzpDsC</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1859314388739686769?ref_src=twsrc%5Etfw">November 20, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Despite the volatile movement in Nvidia and other chipmaker stocks, Wedbush analyst Dan Ives maintained optimism about the AI giant's performance.
"The Godfather of AI Jensen and Nvidia delivered a massive beat and big things ahead for Blackwell," Ives said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The Godfather of AI Jensen and Nvidia delivered a massive beat and big things ahead for Blackwell as we discussed into this big night for the tech world on <a href="https://twitter.com/SquawkStreet?ref_src=twsrc%5Etfw">@SquawkStreet</a> &#x1f3c6;&#x1f525;&#x1f37f;&#x1f402;&#x1f4fa;&#x1f3a4;&#x1f447; <a href="https://t.co/6ehn8D3Gs0">https://t.co/6ehn8D3Gs0</a>
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1859387551351546328?ref_src=twsrc%5Etfw">November 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Nvidia <a href="https://www.benzinga.com/news/earnings/24/11/42099904/nvidia-beats-q3-revenue-eps-estimates-supply-constraints-ding-stock-huang-says-age-of-ai-is-in-full-steam">posted third-quarter revenue</a> of $35.1 billion, up 94% year-on-year, beating the Street consensus of $33.12 billion, according to data <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112024&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">from Benzinga Pro</a>. This was the ninth straight quarter of Nvidia beating analyst estimates.
Tech bull Ives thinks that this is <a href="https://www.benzinga.com/markets/equities/24/11/42102642/nvidia-delivered-jaw-dropping-q3-earnings-says-dan-ives-this-is-the-fourth-revolution-playing-out-in-front-of-our-eyes">the "fourth revolution"</a> in technology, and it could help the Nasdaq surge to 25,000.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How To Trade Futures</a>
Upcoming Economic Data
Thursday's economic calendar includes the release of initial jobless claims data.
<ul>
<li>Initial jobless claims data will be released at 8:30 a.m. ET.</li>
<li>Philadelphia Fed manufacturing survey will be released at 8:30 a.m. ET.</li>
<li>Cleveland Fed President Beth Hammack will speak at 8:45 a.m. ET.</li>
<li>Existing home sales data and leading economic index will be released at 10 a.m. ET.</li>
<li>Kansas City Fed President Jeff Schmid will speak at 1:10 p.m. ET.</li>
<li>Fed Vice Chair for Supervision Michael Barr will speak at 4:40 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares fell 2.6% in premarket trading on Thursday after the company posted a quarter-on-quarter decline in gross margins.</li>
<li>Other chip stocks felt the pressure post-Nvidia earnings. Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) fell nearly 1%, while Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) was down 0.6%. Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) both fell 0.5% in premarket trading.</li>
<li>MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) stock surged over 10% on Wednesday and rose by another 11% in premarket trading on Thursday after Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) <a href="https://www.benzinga.com/24/11/42102366/bitcoin-taps-95k-ethereum-dogecoin-flat-as-trumps-crypto-policy-takes-shape-top-analyst-describes-btcs-path-to-135k">crossed the $95,000 mark</a>. Robinhood Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) stock was also up over 3%.</li>
<li>Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) shares rose over 21% in premarket trading after the company beat analyst expectations and revised its 2025 revenue outlook upwards.</li>
<li>Palo Alto Networks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) stock fell over 4% in premarket trading after the company's third-quarter results.</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) stock was slightly down in premarket trading after the U.S. Department of Justice (DOJ) said the company needed to sell the Google Chrome browser to <a href="https://www.benzinga.com/tech/24/11/42105079/googles-unlawful-behavior-stifles-market-entry-for-rivals-doj-says-alphabet-must-sell-chrome-to-end-search-monopoly">end search monopoly</a>.</li>
<li>Investors are awaiting earnings results from Deere &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), BJ&#8217;s Wholesale Club Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>), and Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) today.</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil futures surged in the early New York session, rising by 1.70% to hover around $69.92 per barrel.
The 10-year Treasury note yield edged lower to 4.394%.
Most of the major Asian markets ended in the red on Thursday, while European markets showed tentativeness in early trading.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/11/42105079/googles-unlawful-behavior-stifles-market-entry-for-rivals-doj-says-alphabet-must-sell-chrome-to-end-search-monopoly">Target Says Shoppers Wait For &#8216;Deals&#8217; A Day After Rival Walmart Credits Market Gains To Wealthy Households</a></li>
</ul>
Photo courtesy: Wikimedia

Earnings

Equities

Futures

Economics

Federal Reserve

Pre-Market Outlook

Movers

Trading Ideas

$BTC

AVGO

GOOG

GOOGL

HOOD

INTC

INTU

MSTR

NVDA

PANW

QCOM

SNOW

US Futures Head Lower As Nvidia Earnings Fail To Impress Investors: Expert Says Market Weakness Is 'Perfectly Normal,' But Late November Rally Is Still Possible

<ul>
<li>Digitally enabled comparable sales growth was 30.0%, reflecting two-year stacked comp growth of 47.0%</li>
<li>Membership fee income increased by 8.4% year-over-year to $115.0 million</li>
</ul>

BJ's Wholesale Club Q3 Comparable Club Sales Increased By 1.5% YoY, Comparable Club Sales, Excluding Gasoline Sales, Increased By 3.8% YoY, Led By Strong Traffic

Barclays analyst Brian Morton upgrades Bank of Nova Scotia (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BNS#TSX">BNS</a>) from Underweight to Equal-Weight and raises the price target from C$70 to C$81.

TSX:BNS

Barclays Upgrades Bank of Nova Scotia to Equal-Weight, Raises Price Target to C$81

NVIDIA Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) experienced a 2.36% decline in pre-market trading on Thursday, as per <a href="https://pro.benzinga.com">Benzinga Pro,</a> despite surpassing Wall Street expectations in its third-quarter earnings. 
What Happened:&nbsp;The chipmaker reported a 94% year-over-year increase in revenue, reaching $35.1 billion, exceeding the anticipated $33.12 billion. Additionally, the company&#8217;s earnings per share were 81 cents, surpassing the projected 75 cents.
Despite these strong financial results, investor concerns arose due to a slowdown in sales compared to previous quarters.&nbsp;Derren Nathan,&nbsp;head of equity research at&nbsp;Hargreaves Lansdown, <a href="https://www.cnbc.com/2024/11/21/nvidia-nvda-stock-slumps-despite-q3-earnings-beat.html">told</a>&nbsp;CNBC&nbsp;that the drop in NVIDIA&#8217;s stock price suggests that &#8220;even&nbsp;outstanding isn't enough for some&nbsp;investors.&#8221;
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42102652/michael-saylors-microstrategy-takes-wall-street-by-storm-becomes-second-most-traded-stock-after-nvidia?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Michael Saylor&#8217;s MicroStrategy Takes Wall Street By Storm, Becomes Second-Most Traded Stock After Nvidia</a>
Why It Matters: This also comes at a time when <a href="https://www.benzinga.com/news/large-cap/24/11/42094649/nvidia-stock-historically-drops-in-december-after-q3-earnings">seasonal statistics have revealed </a>that December has historically been a challenging month for Nvidia investors. The semiconductor giant of Jensen Huang often enters a temporary bearish phase following its third-quarter earnings report. Historical data indicates that while NVIDIA frequently delivers positive third-quarter earnings, December tends to be a negative month for its stock.
Meanwhile, Wedbush Securities Managing Director Dan Ives <a href="https://www.benzinga.com/markets/equities/24/11/42102642/nvidia-delivered-jaw-dropping-q3-earnings-says-dan-ives-this-is-the-fourth-revolution-playing-out-in-front-of-our-eyes">described the results as a "jaw-dropper," </a>emphasizing the transformative potential of the company's AI technology. "This is the fourth revolution playing out in front of our eyes," Ives told CNN, <a href="https://x.com/jchatterleyCNN/status/1859386289315053838" target="_blank" rel="noreferrer noopener">highlighting</a> the broader implications for the tech sector.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/42079984/dogecoin-bitcoin-left-in-the-dust-by-ai-meme-coin-goat-as-nvidias-q3-earnings-draw-near?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Dogecoin, Bitcoin Left In The Dust By AI Meme Coin GOAT As Nvidia&#8217;s Q3 Earnings Draw Near</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Nvidia Slides During Thursday Pre-Market Despite Beating Q3 Estimates: 'Even Outstanding Isn't Enough For Some Investors'

"The innovative research that will be presented at this year's ASH highlights our robust clinical development program and our commitment to exploring novel modalities and therapeutic targets, as we work to improve outcomes and address unmet needs for people with hematologic neoplasms and malignancies," said Dr. Marjorie Green, senior vice president and head of oncology, global clinical development, Merck Research Laboratories.&nbsp;

Merck To Present New Data For Approved And Investigational Medicines Across Multiple Hematologic Malignancies At ASH Annual Meeting From Dec. 7-10

BJ's Wholesale Club (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $0.91 by 29.67 percent. The company reported quarterly sales of $5.10 billion which met the analyst consensus estimate. This is a 3.55 percent increase over sales of $4.92 billion the same period last year.

BJ's Wholesale Club Q3 2024 Adj EPS $1.18 Beats $0.91 Estimate, Sales $5.10B Inline

Needham analyst Matt Dezort maintains Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) with a Buy and raises the price target from $385 to $450.

Needham Maintains Buy on Palo Alto Networks, Raises Price Target to $450

Uber Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) reportedly plans to <a href="https://www.benzinga.com/news/24/08/40625596/uber-pumps-capital-into-nvidia-backed-wayves-series-c-funding-round">invest in autonomous driving firm</a> Pony AI&#8216;s initial public offering in the U.S.
What Happened: Uber is looking to buy over $10 million of shares in the IPO, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-11-21/uber-said-to-be-in-talks-to-invest-in-us-ipo-of-china-s-pony-ai?srnd=homepage-canada">reported</a>, citing people familiar with the matter. However, the investment size has not been finalized and talks are ongoing, the report added.
Uber may also consider a partnership with Pony AI for its self-driving technology outside the U.S., one of the sources told Bloomberg. 
Though Pony AI&#8217;s IPO was initially expected to be priced on Thursday, it is now expected to be priced next week to give the company time to address questions from regulators. The company will issue 20 million American depository shares raising as much as $260 million, according <a href="https://www.sec.gov/Archives/edgar/data/1969302/000110465924120872/tm2310344-28_fwp.htm">to</a> a regulatory filing.
Why It Matters: Pony AI was founded in late 2016 by James Peng and Tiancheng Lou. It operates self-driving fleets in the U.S. and China and has driven nearly 40 million autonomous testing and operation kilometers on open roads worldwide. 
Uber, meanwhile, has <a href="https://www.benzinga.com/markets/equities/24/09/40855784/uber-stock-spikes-as-ceo-praises-waymos-fully-autonomous-trips">partnerships with other autonomous vehicle companies</a> including Alphabet Inc.&#8217;s Waymo and UK&#8217;s Wayve.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42058338/byd-makes-a-million-nevs-in-less-than-2-months" target="_blank" rel="noreferrer noopener">BYD Makes A Million NEVs In Less Than 2 Months After Beating Tesla For The First Time Since 2022 In Quarterly Revenue</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

Media

UBER

Uber Could Pick Up $10M Stake In Chinese Autonomous Driving Firm Pony AI's US IPO: Report

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Pyxis Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYXS#NASDAQ">PYXS</a>) with a Buy and maintains $7 price target.

Reiteration

PYXS

HC Wainwright & Co. Reiterates Buy on Pyxis Oncology, Maintains $7 Price Target

On Wednesday, November 20, U.S. markets closed mixed. The Nasdaq slipped, weighed down by geopolitical tensions and Target&#8217;s disappointing performance. Nvidia declined ahead of earnings, which later underwhelmed. Meanwhile, the Dow edged higher, and the S&amp;P 500 remained flat.
In economic data, U.S. mortgage applications increased by 1.7% for the week ending November 15, up from the 0.5% rise recorded the previous week.
Healthcare, energy, and materials led S&amp;P 500 gains Wednesday, while consumer discretionary and financials declined.
The Dow Jones Industrial Average was up 0.32% and closed at 43,408.47, the S&amp;P 500 gained 0.002% to 5,917.11, and the Nasdaq Composite declined 0.11% to finish at 18,966.14.
Asia Markets Today
<ul>
<li>On Thursday, Japan&#8217;s Nikkei 225 declined 0.97% and ended the session at 38,002.50, led by losses in the Insurance, Transportation Equipment, and Power sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 fell 0.04% and ended the day at 8,323.00, led by losses in the Consumer Discretionary, Consumer Staples, and A-REITs sectors.</li>
<li>India&#8217;s Nifty 50 declined 0.73% to 23,346.70, and Nifty 500 slid 0.85% closing at 21,816.45, led by losses in the Public Sector Undertakings, Oil &amp; Gas and Power sectors.</li>
<li>China&#8217;s Shanghai Composite gained 0.07% to close at 3,370.40, and the Shenzhen CSI 300 rose 0.09%, finishing the day at 3,989.30.</li>
<li>Hong Kong&#8217;s Hang Seng fell 0.53% and closed the session at 19,601.11.</li>
</ul>
Eurozone at 05:30 AM ET
<ul>
<li>The European STOXX 50 index was down 0.36%.</li>
<li>Germany&#8217;s DAX slid 0.02%.</li>
<li>France&#8217;s CAC declined 0.43%.</li>
<li>FTSE 100 index traded higher by 0.20%</li>
</ul>
Commodities at 05:30 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 1.70% at $69.94/bbl, and Brent was up 1.58% at $73.95/bbl.</li>
<li>Oil prices rose amid escalating Russia-Ukraine missile strikes, overshadowing a larger-than-expected U.S. crude inventory increase.</li>
<li>Natural Gas rose 6.45% to $3.297.</li>
<li>Gold was trading higher by 0.78% at $2,672.45, Silver was up 0.35% to $31.115, and Copper fell 0.83% to $4.1210.</li>
</ul>
U.S. Futures at 05:30 AM ET
Dow futures declined 0.07%, S&amp;P 500 futures were down 0.24% and Nasdaq 100 futures fell 0.35%.
Forex at 05:30 AM ET
The U.S. dollar index gained 0.04% to 106.72, the USD/JPY was down 0.64% to 154.44, and the USD/AUD slid 0.08% to 1.5357.
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Emerging Markets

Eurozone

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Mixed; Dollar Hovers Near 52-Week High - Global Markets Today While US Slept

Throughout this NFL-style, three-day combine, prospects from nearly every state are expected to attend, with this year's event expected to host the largest total number of recruits in the event's history and the largest combine-style event in the country.
In connection with their participation in the event, all student-athletes will receive a complimentary one-month trial of the Signing Day Sports app, enhancing their visibility to college recruiters.
By collecting registration fees and offering exclusive apparel for participants and fans, the combine enables the Company to drive immediate income while strengthening its brand presence.&nbsp;
&nbsp;

Signing Day Sports Provides Update On Upcoming 3rd Annual US Army Bowl National Combine; Says Combine Enables Company To Drive Immediate Income While Strengthening Its Brand Presence

China Renaissance analyst Yiwen Zhang downgrades Grab Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) from Buy to Hold and announces $5.4 price target.

Downgrades

GRAB

China Renaissance Downgrades Grab Holdings to Hold, Announces $5.4 Price Target

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Lisata Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTA#NASDAQ">LSTA</a>) with a Buy and maintains $15 price target.

LSTA

HC Wainwright & Co. Reiterates Buy on Lisata Therapeutics, Maintains $15 Price Target

Needham analyst Mike Cikos maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Buy and raises the price target from $160 to $200.

Needham Maintains Buy on Snowflake, Raises Price Target to $200

<ul>
<li>Aphexda is Biolinerx's FDA-Approved Stem Cell Mobilization Agent Indicated In Combination With Filgrastim For Collection And Subsequent Autologous Transplantation In Patients With Multiple Myeloma.</li>
<li>BioLineRx to receive $10 million upfront payment from Ayrmid Ltd. (parent company of Gamida Cell) plus up to $87 million in commercial milestones, as well as royalties on net sales ranging from 18% to 23%.</li>
<li>BioLineRx retains rights to develop and commercialize motixafortide in solid tumors, including PDAC.</li>
<li>BioLineRx received $9 million equity investment from certain funds managed by Highbridge Capital Management, LLC to support company's pipeline and expansion.</li>
<li>Transactions enable significant reduction in BioLineRx's operational expenses and debt, and allow the company to focus on development activities in areas of high unmet need in oncology and rare diseases –</li>
</ul>

Biotech

Contracts

BLRX

BioLineRx And Ayrmid Entered Into A License Agreement For Motixafortide (Commercially Sold In The US As Aphexda), BioLineRx Will Receive A $10M Upfront Payment And Is Also Eligible To Receive Up To An Additional $87M Of Potential Commercial Milestones, Plus Royalties Between 18%-23% On Net Sales Of Aphexda

RIWI GAAP EPS of $0.00, revenue of $1.14M

RIWI GAAP EPS of -$0.01, revenue of $1.03M

RIWI reports Q3 results

Events

Press Releases

RIWI to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024

Comments

RIWI

RIWI (RWCRF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga